Internal Medicine, Hematology & Oncology · Philadelphia, PA
NPI
1407923113
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
925 Chestnut St, Suite 320a
Philadelphia, PA, 19107
Phone (215) 955-8874
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
458 services
Medicare patients, 2024
144
Average age 75
Drug cost, 2024
$3.4M
1,027 prescriptions
Company payments, 2025
$597
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lewis J Rose was code 99215 (office e&m - established), 224 times for 71 patients. In total Lewis J Rose billed 458 services in 12 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 224 | 71 | $136.76 | $31K |
| 99214 Office E&M - Established | Office | 148 | 79 | $93.38 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 28 | 19 | $13.28 | $372 |
| 99205 Office E&M - New | Office | 19 | 19 | $170.38 | $3,237 |
| 99213 Office E&M - Established | Office | 15 | 14 | $55.58 | $834 |
By year: 2022 $59K for 531 services; 2023 $49K for 450 services; 2024 $50K for 458 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lewis J Rose prescribed most often to Medicare patients was Anastrozole, with 106 prescriptions and refills. In total Lewis J Rose wrote 1,027 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 106 | 290 | 30 | $2,160 |
| Eliquis Apixaban | 87 | 146 | 20 | $85K |
| Ondansetron Hcl Generic | 62 | 66 | 38 | $516 |
| Prochlorperazine Maleate Generic | 54 | 54 | 33 | $1,049 |
| Abiraterone Acetate Generic | 42 | 42 | Under 11 | $25K |
| Valacyclovir Valacyclovir Hcl | 32 | 70 | Under 11 | $1,117 |
| Imbruvica Ibrutinib | 30 | 30 | Under 11 | $533K |
| Lenalidomide Generic | 30 | 30 | Under 11 | $361K |
| Exemestane Generic | 27 | 63 | Under 11 | $2,558 |
| Dexamethasone Generic | 24 | 30 | 18 | $805 |
| Gabapentin Generic | 21 | 26 | Under 11 | $293 |
| Prednisone Generic | 21 | 47 | Under 11 | $172 |
| Oxycodone Hcl Generic | 19 | 19 | Under 11 | $192 |
| Verzenio Abemaciclib | 18 | 18 | Under 11 | $202K |
| Potassium Chloride Generic | 18 | 24 | Under 11 | $169 |
Brand drugs: 307 claims; generic drugs: 720 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lewis J Rose $597 ($597 in general payments such as food, travel and fees) from 8 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $164.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.